GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ClearPoint Neuro Inc (NAS:CLPT) » Definitions » Cyclically Adjusted PB Ratio

ClearPoint Neuro (ClearPoint Neuro) Cyclically Adjusted PB Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2012. Start your Free Trial

What is ClearPoint Neuro Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


ClearPoint Neuro Cyclically Adjusted PB Ratio Historical Data

The historical data trend for ClearPoint Neuro's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClearPoint Neuro Cyclically Adjusted PB Ratio Chart

ClearPoint Neuro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ClearPoint Neuro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ClearPoint Neuro's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, ClearPoint Neuro's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClearPoint Neuro's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ClearPoint Neuro's Cyclically Adjusted PB Ratio falls into.



ClearPoint Neuro Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

ClearPoint Neuro's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, ClearPoint Neuro's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.859/129.4194*129.4194
=0.859

Current CPI (Dec. 2023) = 129.4194.

ClearPoint Neuro Quarterly Data

Book Value per Share CPI Adj_Book
201403 -2.130 99.695 -2.765
201406 -3.059 100.560 -3.937
201409 -5.375 100.428 -6.927
201412 -0.053 99.070 -0.069
201503 -1.939 99.621 -2.519
201506 -3.140 100.684 -4.036
201509 -3.106 100.392 -4.004
201512 -0.867 99.792 -1.124
201603 -1.573 100.470 -2.026
201606 -1.651 101.688 -2.101
201609 0.159 101.861 0.202
201612 -0.209 101.863 -0.266
201703 -0.609 102.862 -0.766
201706 0.825 103.349 1.033
201709 0.704 104.136 0.875
201712 0.545 104.011 0.678
201803 0.439 105.290 0.540
201806 0.323 106.317 0.393
201809 0.226 106.507 0.275
201812 0.137 105.998 0.167
201903 0.040 107.251 0.048
201906 0.505 108.070 0.605
201909 0.401 108.329 0.479
201912 0.301 108.420 0.359
202003 0.178 108.902 0.212
202006 0.086 108.767 0.102
202009 0.009 109.815 0.011
202012 0.139 109.897 0.164
202103 2.127 111.754 2.463
202106 2.149 114.631 2.426
202109 1.930 115.734 2.158
202112 2.061 117.630 2.268
202203 1.929 121.301 2.058
202206 1.749 125.017 1.811
202209 1.628 125.227 1.683
202212 1.501 125.222 1.551
202303 1.325 127.348 1.347
202306 1.113 128.729 1.119
202309 0.978 129.860 0.975
202312 0.859 129.419 0.859

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ClearPoint Neuro  (NAS:CLPT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


ClearPoint Neuro Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of ClearPoint Neuro's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ClearPoint Neuro (ClearPoint Neuro) Business Description

Traded in Other Exchanges
N/A
Address
120 S. Sierra Avenue, Suite 100, Solana Beach, CA, USA, 92075
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.
Executives
Lynnette C Fallon director 108 CHERRY HILL DRIVE, BEVERLY MA 01915
Linda M. Liau director 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075
Mazin Sabra officer: Chief Operating Officer 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075
Joseph Michael Burnett director, officer: CEO and President C/O MRI INTERVENTIONS, INC., 5 MUSICK, IRVINE CA 92618
L. Jeremy Stigall officer: GM, Biologics & Drug Delivery 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075
Danilo D'alessandro officer: Vice President, Finance 5 MUSICK, IRVINE CA 92618
Harold A Hurwitz officer: Chief Financial Officer
R John Fletcher director C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Girin Pascal E R director C/O MRI INTERVENTIONS, INC., 5 MUSICK, IRVINE CA 92618
B Kristine Johnson director 366 FERNDALE RD S, WAYZATA MN 55391
Timothy T. Richards director ONE COMMERCE SQUARE, SUITE 2550, MEMPHIS TN 38103
Matthew B. Klein director C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD NJ 07080
Marcio Souza director C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD NJ 07080
Voyager Therapeutics, Inc. 10 percent owner 75 HAYDEN AVENUE, LEXINGTON MA 02421
Wendelin C Maners officer: Vice President, Marketing ONE COMMERCE SQUARE, SUITE 2550, MEMPHIS TN 38103

ClearPoint Neuro (ClearPoint Neuro) Headlines

From GuruFocus

ClearPoint Neuro Announces Receipt of MDSAP Certification

By GuruFocusNews GuruFocusNews 06-22-2022

ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022

By Value_Insider Value_Insider 10-26-2022

ClearPoint Neuro Announces Receipt of MDSAP Certification

By PurpleRose PurpleRose 07-12-2022

ClearPoint Neuro to Present at Upcoming Investor Conferences

By Value_Insider Value_Insider 11-09-2022